#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4 .
1-1	0-1	4	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Roles of Bacterial Virulence Factors During Invasion
2-1	4-9	Roles	person[2]	new[2]	_	_
2-2	10-12	of	person[2]	new[2]	_	_
2-3	13-22	Bacterial	person[2]|abstract[4]	new[2]|new[4]	coref	4-12[12_4]
2-4	23-32	Virulence	person[2]|abstract|abstract[4]	new[2]|new|new[4]	coref	4-13
2-5	33-40	Factors	person[2]|abstract[4]	new[2]|new[4]	_	_
2-6	41-47	During	person[2]|abstract[4]	new[2]|new[4]	_	_
2-7	48-56	Invasion	person[2]|abstract[4]|event	new[2]|new[4]|new	coref	9-17[39_0]

#Text=Through the Barriers of the CNS
3-1	57-64	Through	_	_	_	_
3-2	65-68	the	object[6]	new[6]	coref	14-26[68_6]
3-3	69-77	Barriers	object[6]	new[6]	_	_
3-4	78-80	of	object[6]	new[6]	_	_
3-5	81-84	the	object[6]|place[7]	new[6]|new[7]	coref	4-6[8_7]
3-6	85-88	CNS	object[6]|place[7]	new[6]|new[7]	_	_

#Text=To be able to enter the CNS , bacterial pathogens use several virulence factors , which are involved in the different steps of pathogenesis .
4-1	89-91	To	_	_	_	_
4-2	92-94	be	_	_	_	_
4-3	95-99	able	_	_	_	_
4-4	100-102	to	_	_	_	_
4-5	103-108	enter	_	_	_	_
4-6	109-112	the	place[8]	giv[8]	coref	26-15[105_8]
4-7	113-116	CNS	place[8]	giv[8]	_	_
4-8	117-118	,	_	_	_	_
4-9	119-128	bacterial	abstract|animal[10]	new|new[10]	coref|coref	9-8[0_10]|9-8[0_10]
4-10	129-138	pathogens	animal[10]	new[10]	_	_
4-11	139-142	use	_	_	_	_
4-12	143-150	several	abstract[12]	giv[12]	coref	10-8[49_12]
4-13	151-160	virulence	abstract|abstract[12]	giv|giv[12]	coref	10-9
4-14	161-168	factors	abstract[12]	giv[12]	_	_
4-15	169-170	,	_	_	_	_
4-16	171-176	which	_	_	_	_
4-17	177-180	are	_	_	_	_
4-18	181-189	involved	_	_	_	_
4-19	190-192	in	_	_	_	_
4-20	193-196	the	abstract[13]	new[13]	_	_
4-21	197-206	different	abstract[13]	new[13]	_	_
4-22	207-212	steps	abstract[13]	new[13]	_	_
4-23	213-215	of	abstract[13]	new[13]	_	_
4-24	216-228	pathogenesis	abstract[13]|abstract	new[13]|new	_	_
4-25	229-230	.	_	_	_	_

#Text=Of major importance is the capsule of both gram-positive and gram-negative bacteria .
5-1	231-233	Of	_	_	_	_
5-2	234-239	major	abstract[15]	new[15]	_	_
5-3	240-250	importance	abstract[15]	new[15]	_	_
5-4	251-253	is	_	_	_	_
5-5	254-257	the	object[16]	new[16]	coref	9-4[34_16]
5-6	258-265	capsule	object[16]	new[16]	_	_
5-7	266-268	of	object[16]	new[16]	_	_
5-8	269-273	both	object[16]|animal[17]	new[16]|new[17]	coref	10-14[50_17]
5-9	274-287	gram-positive	object[16]|animal[17]	new[16]|new[17]	_	_
5-10	288-291	and	object[16]|animal[17]	new[16]|new[17]	_	_
5-11	292-305	gram-negative	object[16]|animal[17]	new[16]|new[17]	_	_
5-12	306-314	bacteria	object[16]|animal[17]	new[16]|new[17]	_	_
5-13	315-316	.	_	_	_	_

#Text=The capsular polysaccharide has a protective function in bloodstream survival .
6-1	317-320	The	substance[19]	new[19]	_	_
6-2	321-329	capsular	abstract|substance[19]	new|new[19]	_	_
6-3	330-344	polysaccharide	substance[19]	new[19]	_	_
6-4	345-348	has	_	_	_	_
6-5	349-350	a	abstract[20]	new[20]	ana	7-3[0_20]
6-6	351-361	protective	abstract[20]	new[20]	_	_
6-7	362-370	function	abstract[20]	new[20]	_	_
6-8	371-373	in	abstract[20]	new[20]	_	_
6-9	374-385	bloodstream	abstract[20]|abstract|event[22]	new[20]|new|new[22]	ana|ana	8-1[0_22]|8-1[0_22]
6-10	386-394	survival	abstract[20]|event[22]	new[20]|new[22]	_	_
6-11	395-396	.	_	_	_	_

#Text=However , it was observed to attenuate invasion of the BBB and BCSFB .
7-1	397-404	However	_	_	_	_
7-2	405-406	,	_	_	_	_
7-3	407-409	it	abstract	giv	_	_
7-4	410-413	was	_	_	_	_
7-5	414-422	observed	_	_	_	_
7-6	423-425	to	_	_	_	_
7-7	426-435	attenuate	_	_	_	_
7-8	436-444	invasion	abstract[24]	new[24]	_	_
7-9	445-447	of	abstract[24]	new[24]	_	_
7-10	448-451	the	abstract[24]|organization[25]|object[26]	new[24]|new[25]|new[26]	coref|coref|coref|coref	22-13[88_25]|22-13[89_26]|22-13[88_25]|22-13[89_26]
7-11	452-455	BBB	abstract[24]|organization[25]|object[26]	new[24]|new[25]|new[26]	_	_
7-12	456-459	and	abstract[24]|object[26]	new[24]|new[26]	_	_
7-13	460-465	BCSFB	abstract[24]|object[26]|object	new[24]|new[26]|new	coref	22-16
7-14	466-467	.	_	_	_	_

#Text=This could result from electrostatic repulsion or from the masking of bacterial surface structures .
8-1	468-472	This	event	giv	coref	9-7[36_0]
8-2	473-478	could	_	_	_	_
8-3	479-485	result	abstract	new	none|none	8-3[0_193]|37-14
8-4	486-490	from	_	_	_	_
8-5	491-504	electrostatic	abstract[29]	new[29]	_	_
8-6	505-514	repulsion	abstract[29]	new[29]	_	_
8-7	515-517	or	_	_	_	_
8-8	518-522	from	_	_	_	_
8-9	523-526	the	abstract[30]	new[30]	_	_
8-10	527-534	masking	abstract[30]	new[30]	_	_
8-11	535-537	of	abstract[30]	new[30]	_	_
8-12	538-547	bacterial	abstract[30]|object[32]	new[30]|new[32]	_	_
8-13	548-555	surface	abstract[30]|place|object[32]	new[30]|new|new[32]	_	_
8-14	556-566	structures	abstract[30]|object[32]	new[30]|new[32]	_	_
8-15	567-568	.	_	_	_	_

#Text=The necessity of the capsule for the pathogens survival in the blood but simultaneous hindrance of invasion of the host ’s tissues indicates a need for the regulation of capsule expression .
9-1	569-572	The	abstract[33]	new[33]	_	_
9-2	573-582	necessity	abstract[33]	new[33]	_	_
9-3	583-585	of	abstract[33]	new[33]	_	_
9-4	586-589	the	abstract[33]|object[34]	new[33]|giv[34]	coref	9-30[0_34]
9-5	590-597	capsule	abstract[33]|object[34]	new[33]|giv[34]	_	_
9-6	598-601	for	abstract[33]|object[34]	new[33]|giv[34]	_	_
9-7	602-605	the	abstract[33]|object[34]|event[36]	new[33]|giv[34]|giv[36]	_	_
9-8	606-615	pathogens	abstract[33]|object[34]|animal|event[36]	new[33]|giv[34]|giv|giv[36]	_	_
9-9	616-624	survival	abstract[33]|object[34]|event[36]	new[33]|giv[34]|giv[36]	_	_
9-10	625-627	in	abstract[33]|object[34]|event[36]	new[33]|giv[34]|giv[36]	_	_
9-11	628-631	the	abstract[33]|object[34]|event[36]|substance[37]	new[33]|giv[34]|giv[36]|new[37]	coref	14-23[66_37]
9-12	632-637	blood	abstract[33]|object[34]|event[36]|substance[37]	new[33]|giv[34]|giv[36]|new[37]	_	_
9-13	638-641	but	_	_	_	_
9-14	642-654	simultaneous	abstract[38]	new[38]	_	_
9-15	655-664	hindrance	abstract[38]	new[38]	_	_
9-16	665-667	of	abstract[38]	new[38]	_	_
9-17	668-676	invasion	abstract[38]|event[39]	new[38]|giv[39]	_	_
9-18	677-679	of	abstract[38]|event[39]	new[38]|giv[39]	_	_
9-19	680-683	the	abstract[38]|event[39]|object[41]	new[38]|giv[39]|new[41]	_	_
9-20	684-688	host	abstract[38]|event[39]|person[40]|object[41]	new[38]|giv[39]|new[40]|new[41]	coref	23-9[94_40]
9-21	689-691	’s	abstract[38]|event[39]|person[40]|object[41]	new[38]|giv[39]|new[40]|new[41]	_	_
9-22	692-699	tissues	abstract[38]|event[39]|object[41]	new[38]|giv[39]|new[41]	_	_
9-23	700-709	indicates	_	_	_	_
9-24	710-711	a	abstract[42]	new[42]	_	_
9-25	712-716	need	abstract[42]	new[42]	_	_
9-26	717-720	for	abstract[42]	new[42]	_	_
9-27	721-724	the	abstract[42]|abstract[43]	new[42]|new[43]	_	_
9-28	725-735	regulation	abstract[42]|abstract[43]	new[42]|new[43]	_	_
9-29	736-738	of	abstract[42]|abstract[43]	new[42]|new[43]	_	_
9-30	739-746	capsule	abstract[42]|abstract[43]|object|abstract[45]	new[42]|new[43]|giv|new[45]	coref|coref	10-2[46_0]|10-2[46_0]
9-31	747-757	expression	abstract[42]|abstract[43]|abstract[45]	new[42]|new[43]|new[45]	_	_
9-32	758-759	.	_	_	_	_

#Text=Besides the capsule , a multitude of further virulence factors are used by gram-positive and gram-negative bacteria .
10-1	760-767	Besides	_	_	_	_
10-2	768-771	the	object[46]	giv[46]	_	_
10-3	772-779	capsule	object[46]	giv[46]	_	_
10-4	780-781	,	_	_	_	_
10-5	782-783	a	abstract[47]	new[47]	_	_
10-6	784-793	multitude	abstract[47]	new[47]	_	_
10-7	794-796	of	abstract[47]	new[47]	_	_
10-8	797-804	further	abstract[47]|abstract[49]	new[47]|giv[49]	coref	11-15[0_49]
10-9	805-814	virulence	abstract[47]|abstract|abstract[49]	new[47]|giv|giv[49]	coref	14-10
10-10	815-822	factors	abstract[47]|abstract[49]	new[47]|giv[49]	_	_
10-11	823-826	are	_	_	_	_
10-12	827-831	used	_	_	_	_
10-13	832-834	by	_	_	_	_
10-14	835-848	gram-positive	animal[50]	giv[50]	coref	15-8[72_50]
10-15	849-852	and	animal[50]	giv[50]	_	_
10-16	853-866	gram-negative	animal[50]	giv[50]	_	_
10-17	867-875	bacteria	animal[50]	giv[50]	_	_
10-18	876-877	.	_	_	_	_

#Text=These include , among others , adhesins and internalins , pore-forming toxins , and factors involved in intracellular movement as well as cell-to cell spread and are summarized in
11-1	878-883	These	_	_	_	_
11-2	884-891	include	_	_	_	_
11-3	892-893	,	_	_	_	_
11-4	894-899	among	_	_	_	_
11-5	900-906	others	_	_	_	_
11-6	907-908	,	_	_	_	_
11-7	909-917	adhesins	abstract	new	_	_
11-8	918-921	and	_	_	_	_
11-9	922-933	internalins	substance	new	_	_
11-10	934-935	,	_	_	_	_
11-11	936-948	pore-forming	substance[53]	new[53]	_	_
11-12	949-955	toxins	substance[53]	new[53]	_	_
11-13	956-957	,	_	_	_	_
11-14	958-961	and	_	_	_	_
11-15	962-969	factors	abstract	giv	coref	14-8[61_0]
11-16	970-978	involved	_	_	_	_
11-17	979-981	in	_	_	_	_
11-18	982-995	intracellular	abstract[55]	new[55]	_	_
11-19	996-1004	movement	abstract[55]	new[55]	_	_
11-20	1005-1007	as	_	_	_	_
11-21	1008-1012	well	_	_	_	_
11-22	1013-1015	as	_	_	_	_
11-23	1016-1023	cell-to	place[56]	new[56]	_	_
11-24	1024-1028	cell	place[56]	new[56]	_	_
11-25	1029-1035	spread	_	_	_	_
11-26	1036-1039	and	_	_	_	_
11-27	1040-1043	are	_	_	_	_
11-28	1044-1054	summarized	_	_	_	_
11-29	1055-1057	in	_	_	_	_

#Text=Figure 2
12-1	1058-1064	Figure	abstract[57]	new[57]	_	_
12-2	1065-1066	2	abstract[57]	new[57]	_	_

#Text=.
13-1	1067-1068	.	_	_	_	_

#Text=In this review , we will focus particularly on virulence factors , for which evidence for an involvement during brain entry across the blood – brain barriers has been proposed .
14-1	1069-1071	In	_	_	_	_
14-2	1072-1076	this	abstract[58]	new[58]	_	_
14-3	1077-1083	review	abstract[58]	new[58]	_	_
14-4	1084-1085	,	_	_	_	_
14-5	1086-1088	we	person	acc	_	_
14-6	1089-1093	will	_	_	_	_
14-7	1094-1099	focus	_	_	_	_
14-8	1100-1112	particularly	abstract[61]	giv[61]	coref	15-4[71_61]
14-9	1113-1115	on	abstract[61]	giv[61]	_	_
14-10	1116-1125	virulence	abstract|abstract[61]	giv|giv[61]	coref	15-5
14-11	1126-1133	factors	abstract[61]	giv[61]	_	_
14-12	1134-1135	,	_	_	_	_
14-13	1136-1139	for	_	_	_	_
14-14	1140-1145	which	abstract[62]	new[62]	_	_
14-15	1146-1154	evidence	abstract[62]	new[62]	_	_
14-16	1155-1158	for	abstract[62]	new[62]	_	_
14-17	1159-1161	an	abstract[62]|abstract[63]	new[62]|new[63]	_	_
14-18	1162-1173	involvement	abstract[62]|abstract[63]	new[62]|new[63]	_	_
14-19	1174-1180	during	abstract[62]|abstract[63]	new[62]|new[63]	_	_
14-20	1181-1186	brain	abstract[62]|abstract[63]|object|place[65]	new[62]|new[63]|new|new[65]	coref|coref	14-26|14-26
14-21	1187-1192	entry	abstract[62]|abstract[63]|place[65]	new[62]|new[63]|new[65]	_	_
14-22	1193-1199	across	abstract[62]|abstract[63]|place[65]	new[62]|new[63]|new[65]	_	_
14-23	1200-1203	the	abstract[62]|abstract[63]|place[65]|substance[66]	new[62]|new[63]|new[65]|giv[66]	coref	24-25[0_66]
14-24	1204-1209	blood	abstract[62]|abstract[63]|place[65]|substance[66]	new[62]|new[63]|new[65]|giv[66]	_	_
14-25	1210-1211	–	_	_	_	_
14-26	1212-1217	brain	object|object[68]	giv|giv[68]	coref|coref|coref|coref	22-4[86_68]|22-10[87_0]|22-4[86_68]|22-10[87_0]
14-27	1218-1226	barriers	object[68]	giv[68]	_	_
14-28	1227-1230	has	_	_	_	_
14-29	1231-1235	been	_	_	_	_
14-30	1236-1244	proposed	_	_	_	_
14-31	1245-1246	.	_	_	_	_

#Text=A summary of these virulence factors for gram-positive and gram-negative bacteria is given in Table 1 at the end of this section .
15-1	1247-1248	A	abstract[69]	new[69]	_	_
15-2	1249-1256	summary	abstract[69]	new[69]	_	_
15-3	1257-1259	of	abstract[69]	new[69]	_	_
15-4	1260-1265	these	abstract[69]|abstract[71]	new[69]|giv[71]	_	_
15-5	1266-1275	virulence	abstract[69]|abstract|abstract[71]	new[69]|giv|giv[71]	_	_
15-6	1276-1283	factors	abstract[69]|abstract[71]	new[69]|giv[71]	_	_
15-7	1284-1287	for	abstract[69]|abstract[71]	new[69]|giv[71]	_	_
15-8	1288-1301	gram-positive	abstract[69]|abstract[71]|animal[72]	new[69]|giv[71]|giv[72]	_	_
15-9	1302-1305	and	abstract[69]|abstract[71]|animal[72]	new[69]|giv[71]|giv[72]	_	_
15-10	1306-1319	gram-negative	abstract[69]|abstract[71]|animal[72]	new[69]|giv[71]|giv[72]	_	_
15-11	1320-1328	bacteria	abstract[69]|abstract[71]|animal[72]	new[69]|giv[71]|giv[72]	_	_
15-12	1329-1331	is	_	_	_	_
15-13	1332-1337	given	_	_	_	_
15-14	1338-1340	in	_	_	_	_
15-15	1341-1346	Table	object[73]	new[73]	_	_
15-16	1347-1348	1	object[73]	new[73]	_	_
15-17	1349-1351	at	_	_	_	_
15-18	1352-1355	the	abstract[74]	new[74]	_	_
15-19	1356-1359	end	abstract[74]	new[74]	_	_
15-20	1360-1362	of	abstract[74]	new[74]	_	_
15-21	1363-1367	this	abstract[74]|abstract[75]	new[74]|new[75]	_	_
15-22	1368-1375	section	abstract[74]|abstract[75]	new[74]|new[75]	_	_
15-23	1376-1377	.	_	_	_	_

#Text=4.1 .
16-1	1378-1381	4.1	abstract	new	_	_
16-2	1382-1383	.	_	_	_	_

#Text=Gram-Positive Bacteria
17-1	1384-1397	Gram-Positive	substance[77]	new[77]	_	_
17-2	1398-1406	Bacteria	substance[77]	new[77]	_	_

#Text=4.1.1 .
18-1	1407-1412	4.1.1	abstract	new	_	_
18-2	1413-1414	.	_	_	_	_

#Text=Listeria Monocytogenes
19-1	1415-1423	Listeria	person|abstract[80]	new|new[80]	coref|coref|coref|coref	20-1|20-1[82_80]|20-1|20-1[82_80]
19-2	1424-1437	Monocytogenes	abstract[80]	new[80]	_	_

#Text=Listeria monocytogenes
20-1	1438-1446	Listeria	person|abstract[82]	giv|giv[82]	coref|coref	21-2[83_82]|21-2[83_82]
20-2	1447-1460	monocytogenes	abstract[82]	giv[82]	_	_

#Text=( L. monocytogenes ) is a facultative intracellular gram-positive bacterium .
21-1	1461-1462	(	_	_	_	_
21-2	1463-1465	L.	animal[83]	giv[83]	coref	21-6[84_83]
21-3	1466-1479	monocytogenes	animal[83]	giv[83]	_	_
21-4	1480-1481	)	_	_	_	_
21-5	1482-1484	is	_	_	_	_
21-6	1485-1486	a	animal[84]	giv[84]	ana	22-1[0_84]
21-7	1487-1498	facultative	animal[84]	giv[84]	_	_
21-8	1499-1512	intracellular	animal[84]	giv[84]	_	_
21-9	1513-1526	gram-positive	animal[84]	giv[84]	_	_
21-10	1527-1536	bacterium	animal[84]	giv[84]	_	_
21-11	1537-1538	.	_	_	_	_

#Text=It can traverse several physiological barriers and finally enter the brain via the BBB or BCSFB , especially in immunocompromised individuals .
22-1	1539-1541	It	animal	giv	ana	23-1
22-2	1542-1545	can	_	_	_	_
22-3	1546-1554	traverse	abstract	new	none|none	22-3|24-6
22-4	1555-1562	several	object[86]	giv[86]	_	_
22-5	1563-1576	physiological	object[86]	giv[86]	_	_
22-6	1577-1585	barriers	object[86]	giv[86]	_	_
22-7	1586-1589	and	_	_	_	_
22-8	1590-1597	finally	_	_	_	_
22-9	1598-1603	enter	_	_	_	_
22-10	1604-1607	the	object[87]	giv[87]	coref	26-21[107_87]
22-11	1608-1613	brain	object[87]	giv[87]	_	_
22-12	1614-1617	via	object[87]	giv[87]	_	_
22-13	1618-1621	the	object[87]|object[88]|object[89]	giv[87]|giv[88]|giv[89]	coref|coref|coref|coref	27-7[109_88]|33-14[146_89]|27-7[109_88]|33-14[146_89]
22-14	1622-1625	BBB	object[87]|object[88]|object[89]	giv[87]|giv[88]|giv[89]	_	_
22-15	1626-1628	or	object[87]|object[89]	giv[87]|giv[89]	_	_
22-16	1629-1634	BCSFB	object[87]|object[89]|object	giv[87]|giv[89]|giv	coref	27-10[110_0]
22-17	1635-1636	,	_	_	_	_
22-18	1637-1647	especially	person[91]	new[91]	_	_
22-19	1648-1650	in	person[91]	new[91]	_	_
22-20	1651-1668	immunocompromised	person[91]	new[91]	_	_
22-21	1669-1680	individuals	person[91]	new[91]	_	_
22-22	1681-1682	.	_	_	_	_

#Text=It is ingested through highly contaminated food by the host .
23-1	1683-1685	It	animal	giv	coref	24-4[95_0]
23-2	1686-1688	is	_	_	_	_
23-3	1689-1697	ingested	_	_	_	_
23-4	1698-1705	through	_	_	_	_
23-5	1706-1712	highly	substance[93]	new[93]	_	_
23-6	1713-1725	contaminated	substance[93]	new[93]	_	_
23-7	1726-1730	food	substance[93]	new[93]	_	_
23-8	1731-1733	by	substance[93]	new[93]	_	_
23-9	1734-1737	the	substance[93]|person[94]	new[93]|giv[94]	coref	29-8[120_94]
23-10	1738-1742	host	substance[93]|person[94]	new[93]|giv[94]	_	_
23-11	1743-1744	.	_	_	_	_

#Text=Once ingested , L. monocytogenes traverses the intestinal epithelial barrier into the lamina propria followed by dissemination of the pathogen via the lymph and blood .
24-1	1745-1749	Once	_	_	_	_
24-2	1750-1758	ingested	_	_	_	_
24-3	1759-1760	,	_	_	_	_
24-4	1761-1763	L.	person[95]	giv[95]	coref	25-1[101_95]
24-5	1764-1777	monocytogenes	person[95]	giv[95]	_	_
24-6	1778-1787	traverses	abstract	new	coref	37-27[184_0]
24-7	1788-1791	the	object[96]	new[96]	_	_
24-8	1792-1802	intestinal	object[96]	new[96]	_	_
24-9	1803-1813	epithelial	object[96]	new[96]	_	_
24-10	1814-1821	barrier	object[96]	new[96]	_	_
24-11	1822-1826	into	_	_	_	_
24-12	1827-1830	the	_	_	_	_
24-13	1831-1837	lamina	_	_	_	_
24-14	1838-1845	propria	_	_	_	_
24-15	1846-1854	followed	_	_	_	_
24-16	1855-1857	by	_	_	_	_
24-17	1858-1871	dissemination	event[97]	new[97]	_	_
24-18	1872-1874	of	event[97]	new[97]	_	_
24-19	1875-1878	the	event[97]|object[98]	new[97]|new[98]	coref	31-7[140_98]
24-20	1879-1887	pathogen	event[97]|object[98]	new[97]|new[98]	_	_
24-21	1888-1891	via	event[97]|object[98]	new[97]|new[98]	_	_
24-22	1892-1895	the	event[97]|object[98]|person[99]	new[97]|new[98]|new[99]	_	_
24-23	1896-1901	lymph	event[97]|object[98]|person[99]	new[97]|new[98]|new[99]	_	_
24-24	1902-1905	and	event[97]|object[98]	new[97]|new[98]	_	_
24-25	1906-1911	blood	event[97]|object[98]|substance	new[97]|new[98]|giv	_	_
24-26	1912-1913	.	_	_	_	_

#Text=L. monocytogenes
25-1	1914-1916	L.	person[101]	giv[101]	coref	28-1[118_101]
25-2	1917-1930	monocytogenes	person[101]	giv[101]	_	_

#Text=has multiple target organs , including the liver and spleen , and can enter the CNS across the barriers of the brain .
26-1	1931-1934	has	_	_	_	_
26-2	1935-1943	multiple	object[102]	new[102]	_	_
26-3	1944-1950	target	object[102]	new[102]	_	_
26-4	1951-1957	organs	object[102]	new[102]	_	_
26-5	1958-1959	,	object[102]	new[102]	_	_
26-6	1960-1969	including	object[102]	new[102]	_	_
26-7	1970-1973	the	object[102]|object[103]	new[102]|new[103]	_	_
26-8	1974-1979	liver	object[102]|object[103]	new[102]|new[103]	_	_
26-9	1980-1983	and	object[102]	new[102]	_	_
26-10	1984-1990	spleen	object[102]|object	new[102]|new	_	_
26-11	1991-1992	,	_	_	_	_
26-12	1993-1996	and	_	_	_	_
26-13	1997-2000	can	_	_	_	_
26-14	2001-2006	enter	_	_	_	_
26-15	2007-2010	the	place[105]	giv[105]	_	_
26-16	2011-2014	CNS	place[105]	giv[105]	_	_
26-17	2015-2021	across	place[105]	giv[105]	_	_
26-18	2022-2025	the	place[105]|place[106]	giv[105]|new[106]	_	_
26-19	2026-2034	barriers	place[105]|place[106]	giv[105]|new[106]	_	_
26-20	2035-2037	of	place[105]|place[106]	giv[105]|new[106]	_	_
26-21	2038-2041	the	place[105]|place[106]|object[107]	giv[105]|new[106]|giv[107]	coref	34-29[158_107]
26-22	2042-2047	brain	place[105]|place[106]|object[107]	giv[105]|new[106]|giv[107]	_	_
26-23	2048-2049	.	_	_	_	_

#Text=In addition to direct traversal of the BBB and BCSFB via the transcellular route , transportation across the BBB within leukocytes and retrograde migration within axons of cranial nerves have been described .
27-1	2050-2052	In	_	_	_	_
27-2	2053-2061	addition	_	_	_	_
27-3	2062-2064	to	_	_	_	_
27-4	2065-2071	direct	event[108]	new[108]	_	_
27-5	2072-2081	traversal	event[108]	new[108]	_	_
27-6	2082-2084	of	event[108]	new[108]	_	_
27-7	2085-2088	the	event[108]|organization[109]	new[108]|giv[109]	coref	27-18[113_109]
27-8	2089-2092	BBB	event[108]|organization[109]	new[108]|giv[109]	_	_
27-9	2093-2096	and	event[108]	new[108]	_	_
27-10	2097-2102	BCSFB	event[108]|object[110]	new[108]|giv[110]	coref	33-17[0_110]
27-11	2103-2106	via	event[108]|object[110]	new[108]|giv[110]	_	_
27-12	2107-2110	the	event[108]|object[110]|abstract[111]	new[108]|giv[110]|new[111]	_	_
27-13	2111-2124	transcellular	event[108]|object[110]|abstract[111]	new[108]|giv[110]|new[111]	_	_
27-14	2125-2130	route	event[108]|object[110]|abstract[111]	new[108]|giv[110]|new[111]	_	_
27-15	2131-2132	,	_	_	_	_
27-16	2133-2147	transportation	abstract[112]	new[112]	_	_
27-17	2148-2154	across	abstract[112]	new[112]	_	_
27-18	2155-2158	the	abstract[112]|organization[113]	new[112]|giv[113]	coref	33-14[145_113]
27-19	2159-2162	BBB	abstract[112]|organization[113]	new[112]|giv[113]	_	_
27-20	2163-2169	within	abstract[112]|organization[113]	new[112]|giv[113]	_	_
27-21	2170-2180	leukocytes	abstract[112]|organization[113]|place	new[112]|giv[113]|new	_	_
27-22	2181-2184	and	abstract[112]|organization[113]	new[112]|giv[113]	_	_
27-23	2185-2195	retrograde	abstract[112]|organization[113]|event[115]	new[112]|giv[113]|new[115]	_	_
27-24	2196-2205	migration	abstract[112]|organization[113]|event[115]	new[112]|giv[113]|new[115]	_	_
27-25	2206-2212	within	abstract[112]|organization[113]|event[115]	new[112]|giv[113]|new[115]	_	_
27-26	2213-2218	axons	abstract[112]|organization[113]|event[115]|object[116]	new[112]|giv[113]|new[115]|new[116]	_	_
27-27	2219-2221	of	abstract[112]|organization[113]|event[115]|object[116]	new[112]|giv[113]|new[115]|new[116]	_	_
27-28	2222-2229	cranial	abstract[112]|organization[113]|event[115]|object[116]|object[117]	new[112]|giv[113]|new[115]|new[116]|new[117]	_	_
27-29	2230-2236	nerves	abstract[112]|organization[113]|event[115]|object[116]|object[117]	new[112]|giv[113]|new[115]|new[116]|new[117]	_	_
27-30	2237-2241	have	_	_	_	_
27-31	2242-2246	been	_	_	_	_
27-32	2247-2256	described	_	_	_	_
27-33	2257-2258	.	_	_	_	_

#Text=L. monocytogenes
28-1	2259-2261	L.	person[118]	giv[118]	coref	30-7[127_118]
28-2	2262-2275	monocytogenes	person[118]	giv[118]	_	_

#Text=can enter non-phagocytotic cells by hijacking the host ’s receptor-mediated endocytosis machinery using the zipper mechanism .
29-1	2276-2279	can	_	_	_	_
29-2	2280-2285	enter	_	_	_	_
29-3	2286-2302	non-phagocytotic	place[119]	new[119]	coref	36-10[168_119]
29-4	2303-2308	cells	place[119]	new[119]	_	_
29-5	2309-2311	by	_	_	_	_
29-6	2312-2321	hijacking	_	_	_	_
29-7	2322-2325	the	object[122]	new[122]	coref	38-16[191_122]
29-8	2326-2330	host	person[120]|object[122]	giv[120]|new[122]	_	_
29-9	2331-2333	’s	person[120]|object[122]	giv[120]|new[122]	_	_
29-10	2334-2351	receptor-mediated	object[122]	new[122]	_	_
29-11	2352-2363	endocytosis	abstract|object[122]	new|new[122]	coref	31-4[139_0]
29-12	2364-2373	machinery	object[122]	new[122]	_	_
29-13	2374-2379	using	_	_	_	_
29-14	2380-2383	the	abstract[124]	new[124]	coref	49-1[268_124]
29-15	2384-2390	zipper	person|abstract[124]	new|new[124]	_	_
29-16	2391-2400	mechanism	abstract[124]	new[124]	_	_
29-17	2401-2402	.	_	_	_	_

#Text=The two major invasion proteins of L. monocytogenes are internalin ( InlA ) and InlB , which bind to eukaryotic cell membrane members E-cadherin and tyrosine kinase receptor protein Met , respectively .
30-1	2403-2406	The	abstract[126]	new[126]	coref	30-10[0_126]
30-2	2407-2410	two	abstract[126]	new[126]	_	_
30-3	2411-2416	major	abstract[126]	new[126]	_	_
30-4	2417-2425	invasion	event|abstract[126]	new|new[126]	coref	33-12[144_0]
30-5	2426-2434	proteins	abstract[126]	new[126]	_	_
30-6	2435-2437	of	abstract[126]	new[126]	_	_
30-7	2438-2440	L.	abstract[126]|abstract[127]	new[126]|giv[127]	coref	32-1[141_127]
30-8	2441-2454	monocytogenes	abstract[126]|abstract[127]	new[126]|giv[127]	_	_
30-9	2455-2458	are	_	_	_	_
30-10	2459-2469	internalin	abstract	giv	appos	30-12
30-11	2470-2471	(	_	_	_	_
30-12	2472-2476	InlA	abstract	giv	_	_
30-13	2477-2478	)	_	_	_	_
30-14	2479-2482	and	_	_	_	_
30-15	2483-2487	InlB	plant	new	_	_
30-16	2488-2489	,	_	_	_	_
30-17	2490-2495	which	_	_	_	_
30-18	2496-2500	bind	_	_	_	_
30-19	2501-2503	to	_	_	_	_
30-20	2504-2514	eukaryotic	person[132]	new[132]	_	_
30-21	2515-2519	cell	person[132]	new[132]	_	_
30-22	2520-2528	membrane	place|person[132]	new|new[132]	coref	46-29
30-23	2529-2536	members	person[132]	new[132]	_	_
30-24	2537-2547	E-cadherin	object	new	coref	38-8
30-25	2548-2551	and	_	_	_	_
30-26	2552-2560	tyrosine	abstract|substance[137]	new|new[137]	coref|coref	34-13[0_137]|34-13[0_137]
30-27	2561-2567	kinase	object|substance[137]	new|new[137]	coref	50-9[276_0]
30-28	2568-2576	receptor	substance|substance[137]	new|new[137]	_	_
30-29	2577-2584	protein	substance[137]	new[137]	_	_
30-30	2585-2588	Met	_	_	_	_
30-31	2589-2590	,	_	_	_	_
30-32	2591-2603	respectively	_	_	_	_
30-33	2604-2605	.	_	_	_	_

#Text=These interactions induce receptor-mediated endocytosis of the pathogen .
31-1	2606-2611	These	event[138]	new[138]	_	_
31-2	2612-2624	interactions	event[138]	new[138]	_	_
31-3	2625-2631	induce	_	_	_	_
31-4	2632-2649	receptor-mediated	abstract[139]	giv[139]	coref	38-18[0_139]
31-5	2650-2661	endocytosis	abstract[139]	giv[139]	_	_
31-6	2662-2664	of	abstract[139]	giv[139]	_	_
31-7	2665-2668	the	abstract[139]|object[140]	giv[139]|giv[140]	coref	40-25[0_140]
31-8	2669-2677	pathogen	abstract[139]|object[140]	giv[139]|giv[140]	_	_
31-9	2678-2679	.	_	_	_	_

#Text=L. monocytogenes
32-1	2680-2682	L.	person[141]	giv[141]	coref	35-11[163_141]
32-2	2683-2696	monocytogenes	person[141]	giv[141]	_	_

#Text=has been demonstrated to use one or both internalins to mediate invasion of the BBB and BCSFB .
33-1	2697-2700	has	_	_	_	_
33-2	2701-2705	been	_	_	_	_
33-3	2706-2718	demonstrated	_	_	_	_
33-4	2719-2721	to	_	_	_	_
33-5	2722-2725	use	_	_	_	_
33-6	2726-2729	one	abstract	new	_	_
33-7	2730-2732	or	_	_	_	_
33-8	2733-2737	both	substance[143]	new[143]	_	_
33-9	2738-2749	internalins	substance[143]	new[143]	_	_
33-10	2750-2752	to	_	_	_	_
33-11	2753-2760	mediate	_	_	_	_
33-12	2761-2769	invasion	event[144]	giv[144]	_	_
33-13	2770-2772	of	event[144]	giv[144]	_	_
33-14	2773-2776	the	event[144]|place[145]|object[146]	giv[144]|giv[145]|giv[146]	_	_
33-15	2777-2780	BBB	event[144]|place[145]|object[146]	giv[144]|giv[145]|giv[146]	_	_
33-16	2781-2784	and	event[144]|object[146]	giv[144]|giv[146]	_	_
33-17	2785-2790	BCSFB	event[144]|object[146]|object	giv[144]|giv[146]|giv	coref	36-6[165_0]
33-18	2791-2792	.	_	_	_	_

#Text=A recent study has further demonstrated the importance of the bacterial surface protein InlF , showing that interaction with surface vimentin was required for an optimal colonialization of the brain .
34-1	2793-2794	A	abstract[148]	new[148]	coref	41-3[206_148]
34-2	2795-2801	recent	abstract[148]	new[148]	_	_
34-3	2802-2807	study	abstract[148]	new[148]	_	_
34-4	2808-2811	has	_	_	_	_
34-5	2812-2819	further	_	_	_	_
34-6	2820-2832	demonstrated	_	_	_	_
34-7	2833-2836	the	abstract[149]	new[149]	_	_
34-8	2837-2847	importance	abstract[149]	new[149]	_	_
34-9	2848-2850	of	abstract[149]	new[149]	_	_
34-10	2851-2854	the	abstract[149]|abstract[153]	new[149]|new[153]	_	_
34-11	2855-2864	bacterial	abstract[149]|substance|abstract[153]	new[149]|new|new[153]	coref	37-17
34-12	2865-2872	surface	abstract[149]|place|abstract[153]	new[149]|new|new[153]	coref	34-20
34-13	2873-2880	protein	abstract[149]|substance|abstract[153]	new[149]|giv|new[153]	_	_
34-14	2881-2885	InlF	abstract[149]|abstract[153]	new[149]|new[153]	_	_
34-15	2886-2887	,	_	_	_	_
34-16	2888-2895	showing	_	_	_	_
34-17	2896-2900	that	abstract[154]	new[154]	_	_
34-18	2901-2912	interaction	abstract[154]	new[154]	_	_
34-19	2913-2917	with	abstract[154]	new[154]	_	_
34-20	2918-2925	surface	abstract[154]|place|substance[156]	new[154]|giv|new[156]	_	_
34-21	2926-2934	vimentin	abstract[154]|substance[156]	new[154]|new[156]	_	_
34-22	2935-2938	was	_	_	_	_
34-23	2939-2947	required	_	_	_	_
34-24	2948-2951	for	_	_	_	_
34-25	2952-2954	an	abstract[157]	new[157]	_	_
34-26	2955-2962	optimal	abstract[157]	new[157]	_	_
34-27	2963-2978	colonialization	abstract[157]	new[157]	_	_
34-28	2979-2981	of	abstract[157]	new[157]	_	_
34-29	2982-2985	the	abstract[157]|object[158]	new[157]|giv[158]	_	_
34-30	2986-2991	brain	abstract[157]|object[158]	new[157]|giv[158]	_	_
34-31	2992-2993	.	_	_	_	_

#Text=The MAPK signaling cascade is activated during the invasion of L. monocytogenes .
35-1	2994-2997	The	abstract[161]	new[161]	_	_
35-2	2998-3002	MAPK	abstract|abstract[161]	new|new[161]	coref	36-18
35-3	3003-3012	signaling	abstract|abstract[161]	new|new[161]	coref	43-5
35-4	3013-3020	cascade	abstract[161]	new[161]	_	_
35-5	3021-3023	is	_	_	_	_
35-6	3024-3033	activated	_	_	_	_
35-7	3034-3040	during	_	_	_	_
35-8	3041-3044	the	event[162]	new[162]	coref	37-16[178_162]
35-9	3045-3053	invasion	event[162]	new[162]	_	_
35-10	3054-3056	of	event[162]	new[162]	_	_
35-11	3057-3059	L.	event[162]|abstract[163]	new[162]|giv[163]	coref	41-20[0_163]
35-12	3060-3073	monocytogenes	event[162]|abstract[163]	new[162]|giv[163]	_	_
35-13	3074-3075	.	_	_	_	_

#Text=In a model system of the BCSFB consisting of choroid plexus epithelial cells , the requirement of MAPK activation for listerial entry was demonstrated .
36-1	3076-3078	In	_	_	_	_
36-2	3079-3080	a	abstract[164]	new[164]	coref	37-20[180_164]
36-3	3081-3086	model	abstract[164]	new[164]	_	_
36-4	3087-3093	system	abstract[164]	new[164]	_	_
36-5	3094-3096	of	abstract[164]	new[164]	_	_
36-6	3097-3100	the	abstract[164]|object[165]	new[164]|giv[165]	coref	37-31[185_165]
36-7	3101-3106	BCSFB	abstract[164]|object[165]	new[164]|giv[165]	_	_
36-8	3107-3117	consisting	_	_	_	_
36-9	3118-3120	of	_	_	_	_
36-10	3121-3128	choroid	object|place[168]	new|giv[168]	coref|coref	41-15[210_168]|41-15[210_168]
36-11	3129-3135	plexus	organization|place[168]	new|giv[168]	_	_
36-12	3136-3146	epithelial	place[168]	giv[168]	_	_
36-13	3147-3152	cells	place[168]	giv[168]	_	_
36-14	3153-3154	,	_	_	_	_
36-15	3155-3158	the	event[169]	new[169]	_	_
36-16	3159-3170	requirement	event[169]	new[169]	_	_
36-17	3171-3173	of	event[169]	new[169]	_	_
36-18	3174-3178	MAPK	event[169]|abstract|abstract[171]	new[169]|giv|new[171]	coref|coref|coref|coref	43-1[222_171]|43-23|43-1[222_171]|43-23
36-19	3179-3189	activation	event[169]|abstract[171]	new[169]|new[171]	_	_
36-20	3190-3193	for	event[169]|abstract[171]	new[169]|new[171]	_	_
36-21	3194-3203	listerial	event[169]|abstract[171]|place[172]	new[169]|new[171]|new[172]	coref	40-21[203_172]
36-22	3204-3209	entry	event[169]|abstract[171]|place[172]	new[169]|new[171]|new[172]	_	_
36-23	3210-3213	was	_	_	_	_
36-24	3214-3226	demonstrated	_	_	_	_
36-25	3227-3228	.	_	_	_	_

#Text=Both extracellular signal-regulated kinases ( ERK ) 1 and 2 and p38 inhibition resulted in decreased bacterial invasion into this model system suggesting their involvement in the pathogens traversal of the BCSFB .
37-1	3229-3233	Both	abstract[173]	new[173]	appos	37-6[0_173]
37-2	3234-3247	extracellular	abstract[173]	new[173]	_	_
37-3	3248-3264	signal-regulated	abstract[173]	new[173]	_	_
37-4	3265-3272	kinases	abstract[173]	new[173]	_	_
37-5	3273-3274	(	_	_	_	_
37-6	3275-3278	ERK	abstract	giv	ana	37-24
37-7	3279-3280	)	_	_	_	_
37-8	3281-3282	1	_	_	_	_
37-9	3283-3286	and	_	_	_	_
37-10	3287-3288	2	_	_	_	_
37-11	3289-3292	and	_	_	_	_
37-12	3293-3296	p38	abstract|abstract[176]	new|new[176]	_	_
37-13	3297-3307	inhibition	abstract[176]	new[176]	_	_
37-14	3308-3316	resulted	abstract	new	coref	39-3[193_0]
37-15	3317-3319	in	_	_	_	_
37-16	3320-3329	decreased	event[178]	giv[178]	coref	41-20[212_178]
37-17	3330-3339	bacterial	animal|event[178]	giv|giv[178]	_	_
37-18	3340-3348	invasion	event[178]	giv[178]	_	_
37-19	3349-3353	into	event[178]	giv[178]	_	_
37-20	3354-3358	this	event[178]|abstract[180]	giv[178]|giv[180]	_	_
37-21	3359-3364	model	event[178]|person|abstract[180]	giv[178]|new|giv[180]	_	_
37-22	3365-3371	system	event[178]|abstract[180]	giv[178]|giv[180]	_	_
37-23	3372-3382	suggesting	_	_	_	_
37-24	3383-3388	their	abstract|abstract[182]	giv|new[182]	_	_
37-25	3389-3400	involvement	abstract[182]	new[182]	_	_
37-26	3401-3403	in	abstract[182]	new[182]	_	_
37-27	3404-3407	the	abstract[182]|abstract[184]	new[182]|new[184]	ana	38-1[0_184]
37-28	3408-3417	pathogens	abstract[182]|substance|abstract[184]	new[182]|new|new[184]	coref	44-9[235_0]
37-29	3418-3427	traversal	abstract[182]|abstract[184]	new[182]|new[184]	_	_
37-30	3428-3430	of	abstract[182]|abstract[184]	new[182]|new[184]	_	_
37-31	3431-3434	the	abstract[182]|abstract[184]|object[185]	new[182]|new[184]|giv[185]	coref	41-11[208_185]
37-32	3435-3440	BCSFB	abstract[182]|abstract[184]|object[185]	new[182]|new[184]|giv[185]	_	_
37-33	3441-3442	.	_	_	_	_

#Text=It was previously described that ubiquitination of E-cadherin and Met leads to the recruitment of the clathrin-mediated endocytosis machinery .
38-1	3443-3445	It	abstract	giv	_	_
38-2	3446-3449	was	_	_	_	_
38-3	3450-3460	previously	_	_	_	_
38-4	3461-3470	described	_	_	_	_
38-5	3471-3475	that	_	_	_	_
38-6	3476-3490	ubiquitination	abstract[187]	new[187]	ana	39-1[0_187]
38-7	3491-3493	of	abstract[187]	new[187]	_	_
38-8	3494-3504	E-cadherin	abstract[187]|substance	new[187]|giv	_	_
38-9	3505-3508	and	_	_	_	_
38-10	3509-3512	Met	_	_	_	_
38-11	3513-3518	leads	_	_	_	_
38-12	3519-3521	to	_	_	_	_
38-13	3522-3525	the	event[189]	new[189]	_	_
38-14	3526-3537	recruitment	event[189]	new[189]	_	_
38-15	3538-3540	of	event[189]	new[189]	_	_
38-16	3541-3544	the	event[189]|object[191]	new[189]|giv[191]	_	_
38-17	3545-3562	clathrin-mediated	event[189]|object[191]	new[189]|giv[191]	_	_
38-18	3563-3574	endocytosis	event[189]|abstract|object[191]	new[189]|giv|giv[191]	coref	41-27
38-19	3575-3584	machinery	event[189]|object[191]	new[189]|giv[191]	_	_
38-20	3585-3586	.	_	_	_	_

#Text=This in turn results in the polymerization of the actin cytoskeleton .
39-1	3587-3591	This	abstract	giv	_	_
39-2	3592-3594	in	_	_	_	_
39-3	3595-3599	turn	abstract[193]	new[193]	_	_
39-4	3600-3607	results	abstract[193]	new[193]	_	_
39-5	3608-3610	in	abstract[193]	new[193]	_	_
39-6	3611-3614	the	abstract[193]|event[194]	new[193]|new[194]	_	_
39-7	3615-3629	polymerization	abstract[193]|event[194]	new[193]|new[194]	_	_
39-8	3630-3632	of	abstract[193]|event[194]	new[193]|new[194]	_	_
39-9	3633-3636	the	abstract[193]|event[194]|object[196]	new[193]|new[194]|new[196]	_	_
39-10	3637-3642	actin	abstract[193]|event[194]|abstract|object[196]	new[193]|new[194]|new|new[196]	coref	40-15
39-11	3643-3655	cytoskeleton	abstract[193]|event[194]|object[196]	new[193]|new[194]|new[196]	_	_
39-12	3656-3657	.	_	_	_	_

#Text=During this process , dynamin recruits several factors that result in two waves of actin rearrangements and subsequently result in the entry of the pathogen inside of vacuoles .
40-1	3658-3664	During	_	_	_	_
40-2	3665-3669	this	abstract[197]	new[197]	_	_
40-3	3670-3677	process	abstract[197]	new[197]	_	_
40-4	3678-3679	,	_	_	_	_
40-5	3680-3687	dynamin	substance	new	_	_
40-6	3688-3696	recruits	_	_	_	_
40-7	3697-3704	several	abstract[199]	new[199]	_	_
40-8	3705-3712	factors	abstract[199]	new[199]	_	_
40-9	3713-3717	that	_	_	_	_
40-10	3718-3724	result	_	_	_	_
40-11	3725-3727	in	_	_	_	_
40-12	3728-3731	two	abstract[200]	new[200]	_	_
40-13	3732-3737	waves	abstract[200]	new[200]	_	_
40-14	3738-3740	of	abstract[200]	new[200]	_	_
40-15	3741-3746	actin	abstract[200]|abstract|abstract[202]	new[200]|giv|new[202]	coref|coref	46-25|46-25
40-16	3747-3761	rearrangements	abstract[200]|abstract[202]	new[200]|new[202]	_	_
40-17	3762-3765	and	abstract[200]	new[200]	_	_
40-18	3766-3778	subsequently	abstract[200]	new[200]	_	_
40-19	3779-3785	result	abstract[200]	new[200]	_	_
40-20	3786-3788	in	abstract[200]	new[200]	_	_
40-21	3789-3792	the	abstract[200]|place[203]	new[200]|giv[203]	_	_
40-22	3793-3798	entry	abstract[200]|place[203]	new[200]|giv[203]	_	_
40-23	3799-3801	of	abstract[200]|place[203]	new[200]|giv[203]	_	_
40-24	3802-3805	the	abstract[200]|place[203]	new[200]|giv[203]	_	_
40-25	3806-3814	pathogen	abstract[200]|place[203]|object	new[200]|giv[203]|giv	_	_
40-26	3815-3821	inside	abstract[200]|place[203]	new[200]|giv[203]	_	_
40-27	3822-3824	of	abstract[200]|place[203]	new[200]|giv[203]	_	_
40-28	3825-3833	vacuoles	abstract[200]|place[203]|object	new[200]|giv[203]|new	_	_
40-29	3834-3835	.	_	_	_	_

#Text=Accordingly , an in vitro study using a model of the BCSFB based on HIBCPP cells , revealed that L. monocytogenes invasion is inhibited if dynamin-mediated endocytosis is blocked .
41-1	3836-3847	Accordingly	_	_	_	_
41-2	3848-3849	,	_	_	_	_
41-3	3850-3852	an	abstract[206]	giv[206]	_	_
41-4	3853-3855	in	abstract[206]	giv[206]	_	_
41-5	3856-3861	vitro	abstract[206]	giv[206]	_	_
41-6	3862-3867	study	abstract[206]	giv[206]	_	_
41-7	3868-3873	using	_	_	_	_
41-8	3874-3875	a	object[207]	new[207]	_	_
41-9	3876-3881	model	object[207]	new[207]	_	_
41-10	3882-3884	of	object[207]	new[207]	_	_
41-11	3885-3888	the	object[207]|object[208]	new[207]|giv[208]	_	_
41-12	3889-3894	BCSFB	object[207]|object[208]	new[207]|giv[208]	_	_
41-13	3895-3900	based	_	_	_	_
41-14	3901-3903	on	_	_	_	_
41-15	3904-3910	HIBCPP	substance|place[210]	new|giv[210]	coref|coref	46-9[249_210]|46-9[249_210]
41-16	3911-3916	cells	place[210]	giv[210]	_	_
41-17	3917-3918	,	_	_	_	_
41-18	3919-3927	revealed	_	_	_	_
41-19	3928-3932	that	_	_	_	_
41-20	3933-3935	L.	person|event[212]	giv|giv[212]	coref|coref	42-6[216_0]|42-6[216_0]
41-21	3936-3949	monocytogenes	event[212]	giv[212]	_	_
41-22	3950-3958	invasion	event[212]	giv[212]	_	_
41-23	3959-3961	is	_	_	_	_
41-24	3962-3971	inhibited	_	_	_	_
41-25	3972-3974	if	_	_	_	_
41-26	3975-3991	dynamin-mediated	_	_	_	_
41-27	3992-4003	endocytosis	abstract	giv	_	_
41-28	4004-4006	is	_	_	_	_
41-29	4007-4014	blocked	_	_	_	_
41-30	4015-4016	.	_	_	_	_

#Text=Another essential virulence factor of L. monocytogenes is the pore-forming cytolysin Listeriolysin O ( LLO ) .
42-1	4017-4024	Another	abstract[215]	new[215]	coref	47-11[261_215]
42-2	4025-4034	essential	abstract[215]	new[215]	_	_
42-3	4035-4044	virulence	abstract|abstract[215]	new|new[215]	coref	47-14
42-4	4045-4051	factor	abstract[215]	new[215]	_	_
42-5	4052-4054	of	abstract[215]	new[215]	_	_
42-6	4055-4057	L.	abstract[215]|substance[216]	new[215]|giv[216]	coref	44-5[0_216]
42-7	4058-4071	monocytogenes	abstract[215]|substance[216]	new[215]|giv[216]	_	_
42-8	4072-4074	is	_	_	_	_
42-9	4075-4078	the	person[218]	new[218]	appos	42-12[220_218]
42-10	4079-4091	pore-forming	object|person[218]	new|new[218]	_	_
42-11	4092-4101	cytolysin	person[218]	new[218]	_	_
42-12	4102-4115	Listeriolysin	place|person[220]	new|giv[220]	_	_
42-13	4116-4117	O	person[220]	giv[220]	_	_
42-14	4118-4119	(	_	_	_	_
42-15	4120-4123	LLO	abstract	new	coref	43-8
42-16	4124-4125	)	_	_	_	_
42-17	4126-4127	.	_	_	_	_

#Text=Activation of the NF-κB signaling pathway by LLO was reported in the human embryonic kidney HEK-293 cell line , as well as MAPK signaling .
43-1	4128-4138	Activation	abstract[222]	giv[222]	_	_
43-2	4139-4141	of	abstract[222]	giv[222]	_	_
43-3	4142-4145	the	abstract[222]|place[225]	giv[222]|new[225]	coref	48-3[266_225]
43-4	4146-4151	NF-κB	abstract[222]|abstract|place[225]	giv[222]|new|new[225]	coref	48-4
43-5	4152-4161	signaling	abstract[222]|abstract|place[225]	giv[222]|giv|new[225]	coref	43-23[232_0]
43-6	4162-4169	pathway	abstract[222]|place[225]	giv[222]|new[225]	_	_
43-7	4170-4172	by	abstract[222]|place[225]	giv[222]|new[225]	_	_
43-8	4173-4176	LLO	abstract[222]|place[225]|substance	giv[222]|new[225]|giv	ana	44-1
43-9	4177-4180	was	_	_	_	_
43-10	4181-4189	reported	_	_	_	_
43-11	4190-4192	in	_	_	_	_
43-12	4193-4196	the	object[230]	new[230]	_	_
43-13	4197-4202	human	object[230]	new[230]	_	_
43-14	4203-4212	embryonic	object[230]	new[230]	_	_
43-15	4213-4219	kidney	place|object[230]	new|new[230]	_	_
43-16	4220-4227	HEK-293	time|object[230]	new|new[230]	_	_
43-17	4228-4232	cell	place|object[230]	new|new[230]	coref	45-3[237_0]
43-18	4233-4237	line	object[230]	new[230]	_	_
43-19	4238-4239	,	_	_	_	_
43-20	4240-4242	as	_	_	_	_
43-21	4243-4247	well	_	_	_	_
43-22	4248-4250	as	_	_	_	_
43-23	4251-4255	MAPK	abstract|abstract[232]	giv|giv[232]	coref|coref	48-5[0_232]|48-5[0_232]
43-24	4256-4265	signaling	abstract[232]	giv[232]	_	_
43-25	4266-4267	.	_	_	_	_

#Text=It is secreted by L. monocytogenes and promotes the pathogens intracellular survival .
44-1	4268-4270	It	substance	giv	coref	45-14
44-2	4271-4273	is	_	_	_	_
44-3	4274-4282	secreted	_	_	_	_
44-4	4283-4285	by	_	_	_	_
44-5	4286-4288	L.	person	giv	coref	46-2[246_0]
44-6	4289-4302	monocytogenes	_	_	_	_
44-7	4303-4306	and	_	_	_	_
44-8	4307-4315	promotes	_	_	_	_
44-9	4316-4319	the	substance[235]	giv[235]	_	_
44-10	4320-4329	pathogens	substance[235]	giv[235]	_	_
44-11	4330-4343	intracellular	event[236]	new[236]	_	_
44-12	4344-4352	survival	event[236]	new[236]	_	_
44-13	4353-4354	.	_	_	_	_

#Text=After entering the host cell , lysis of the vacuole is initiated through LLO and the bacterial phospholipases PlcA and PlcB , and followed by intracellular spread in the cytoplasm .
45-1	4355-4360	After	_	_	_	_
45-2	4361-4369	entering	_	_	_	_
45-3	4370-4373	the	place[237]	giv[237]	_	_
45-4	4374-4378	host	place[237]	giv[237]	_	_
45-5	4379-4383	cell	place[237]	giv[237]	_	_
45-6	4384-4385	,	_	_	_	_
45-7	4386-4391	lysis	event[238]	new[238]	_	_
45-8	4392-4394	of	event[238]	new[238]	_	_
45-9	4395-4398	the	event[238]|object[239]	new[238]|new[239]	_	_
45-10	4399-4406	vacuole	event[238]|object[239]	new[238]|new[239]	_	_
45-11	4407-4409	is	_	_	_	_
45-12	4410-4419	initiated	_	_	_	_
45-13	4420-4427	through	_	_	_	_
45-14	4428-4431	LLO	substance	giv	coref	48-15
45-15	4432-4435	and	_	_	_	_
45-16	4436-4439	the	_	_	_	_
45-17	4440-4449	bacterial	_	_	_	_
45-18	4450-4464	phospholipases	abstract|object[242]	new|new[242]	_	_
45-19	4465-4469	PlcA	object[242]	new[242]	_	_
45-20	4470-4473	and	_	_	_	_
45-21	4474-4478	PlcB	abstract	new	_	_
45-22	4479-4480	,	_	_	_	_
45-23	4481-4484	and	_	_	_	_
45-24	4485-4493	followed	_	_	_	_
45-25	4494-4496	by	_	_	_	_
45-26	4497-4510	intracellular	abstract[244]	new[244]	ana	46-13[0_244]
45-27	4511-4517	spread	abstract[244]	new[244]	_	_
45-28	4518-4520	in	abstract[244]	new[244]	_	_
45-29	4521-4524	the	abstract[244]|place[245]	new[244]|new[245]	coref	46-6[247_245]
45-30	4525-4534	cytoplasm	abstract[244]|place[245]	new[244]|new[245]	_	_
45-31	4535-4536	.	_	_	_	_

#Text=Once L. monocytogenes has reached the cytoplasm of the host´s cells , it has been demonstrated to move around and enter neighboring cells using actin comet tails and membrane protrusions to facilitate its spread .
46-1	4537-4541	Once	_	_	_	_
46-2	4542-4544	L.	object[246]	giv[246]	_	_
46-3	4545-4558	monocytogenes	object[246]	giv[246]	_	_
46-4	4559-4562	has	_	_	_	_
46-5	4563-4570	reached	_	_	_	_
46-6	4571-4574	the	place[247]	giv[247]	_	_
46-7	4575-4584	cytoplasm	place[247]	giv[247]	_	_
46-8	4585-4587	of	place[247]	giv[247]	_	_
46-9	4588-4591	the	place[247]|place[249]	giv[247]|giv[249]	coref	46-22[251_249]
46-10	4592-4598	host´s	place[247]|place|place[249]	giv[247]|new|giv[249]	_	_
46-11	4599-4604	cells	place[247]|place[249]	giv[247]|giv[249]	_	_
46-12	4605-4606	,	_	_	_	_
46-13	4607-4609	it	abstract	giv	coref	46-33[257_0]
46-14	4610-4613	has	_	_	_	_
46-15	4614-4618	been	_	_	_	_
46-16	4619-4631	demonstrated	_	_	_	_
46-17	4632-4634	to	_	_	_	_
46-18	4635-4639	move	_	_	_	_
46-19	4640-4646	around	_	_	_	_
46-20	4647-4650	and	_	_	_	_
46-21	4651-4656	enter	_	_	_	_
46-22	4657-4668	neighboring	place[251]	giv[251]	_	_
46-23	4669-4674	cells	place[251]	giv[251]	_	_
46-24	4675-4680	using	_	_	_	_
46-25	4681-4686	actin	animal|object[254]	giv|new[254]	_	_
46-26	4687-4692	comet	object|object[254]	new|new[254]	_	_
46-27	4693-4698	tails	object[254]	new[254]	_	_
46-28	4699-4702	and	_	_	_	_
46-29	4703-4711	membrane	object|object[256]	giv|new[256]	_	_
46-30	4712-4723	protrusions	object[256]	new[256]	_	_
46-31	4724-4726	to	_	_	_	_
46-32	4727-4737	facilitate	_	_	_	_
46-33	4738-4741	its	abstract[257]	giv[257]	coref	52-23[289_257]
46-34	4742-4748	spread	abstract[257]	giv[257]	_	_
46-35	4749-4750	.	_	_	_	_

#Text=This F-actin-based intracellular motility is dependent on the expression of another essential listerial virulence factor , ActA .
47-1	4751-4755	This	abstract[258]	new[258]	_	_
47-2	4756-4769	F-actin-based	abstract[258]	new[258]	_	_
47-3	4770-4783	intracellular	abstract[258]	new[258]	_	_
47-4	4784-4792	motility	abstract[258]	new[258]	_	_
47-5	4793-4795	is	_	_	_	_
47-6	4796-4805	dependent	_	_	_	_
47-7	4806-4808	on	_	_	_	_
47-8	4809-4812	the	abstract[259]	new[259]	_	_
47-9	4813-4823	expression	abstract[259]	new[259]	_	_
47-10	4824-4826	of	abstract[259]	new[259]	_	_
47-11	4827-4834	another	abstract[259]|abstract[261]	new[259]|giv[261]	appos	47-17[0_261]
47-12	4835-4844	essential	abstract[259]|abstract[261]	new[259]|giv[261]	_	_
47-13	4845-4854	listerial	abstract[259]|abstract[261]	new[259]|giv[261]	_	_
47-14	4855-4864	virulence	abstract[259]|abstract|abstract[261]	new[259]|giv|giv[261]	_	_
47-15	4865-4871	factor	abstract[259]|abstract[261]	new[259]|giv[261]	_	_
47-16	4872-4873	,	_	_	_	_
47-17	4874-4878	ActA	abstract	giv	_	_
47-18	4879-4880	.	_	_	_	_

#Text=Activation of the NF-κB signaling pathway is , as previously described , achieved through LLO .
48-1	4881-4891	Activation	abstract[263]	new[263]	_	_
48-2	4892-4894	of	abstract[263]	new[263]	_	_
48-3	4895-4898	the	abstract[263]|place[266]	new[263]|giv[266]	_	_
48-4	4899-4904	NF-κB	abstract[263]|abstract|place[266]	new[263]|giv|giv[266]	coref	49-4
48-5	4905-4914	signaling	abstract[263]|abstract|place[266]	new[263]|giv|giv[266]	ana	49-6
48-6	4915-4922	pathway	abstract[263]|place[266]	new[263]|giv[266]	_	_
48-7	4923-4925	is	_	_	_	_
48-8	4926-4927	,	_	_	_	_
48-9	4928-4930	as	_	_	_	_
48-10	4931-4941	previously	_	_	_	_
48-11	4942-4951	described	_	_	_	_
48-12	4952-4953	,	_	_	_	_
48-13	4954-4962	achieved	_	_	_	_
48-14	4963-4970	through	_	_	_	_
48-15	4971-4974	LLO	abstract	giv	_	_
48-16	4975-4976	.	_	_	_	_

#Text=Another mechanism involving NF-κB is its activation by InlC , which is secreted intracellularly .
49-1	4977-4984	Another	abstract[268]	giv[268]	coref	49-6[271_268]
49-2	4985-4994	mechanism	abstract[268]	giv[268]	_	_
49-3	4995-5004	involving	_	_	_	_
49-4	5005-5010	NF-κB	substance	giv	ana	50-1
49-5	5011-5013	is	_	_	_	_
49-6	5014-5017	its	abstract|abstract[271]	giv|giv[271]	coref|coref	51-10[279_271]|51-10[279_271]
49-7	5018-5028	activation	abstract[271]	giv[271]	_	_
49-8	5029-5031	by	abstract[271]	giv[271]	_	_
49-9	5032-5036	InlC	abstract[271]|abstract	giv[271]|new	coref	52-1
49-10	5037-5038	,	_	_	_	_
49-11	5039-5044	which	_	_	_	_
49-12	5045-5047	is	_	_	_	_
49-13	5048-5056	secreted	_	_	_	_
49-14	5057-5072	intracellularly	_	_	_	_
49-15	5073-5074	.	_	_	_	_

#Text=It can directly interact with the subunit of the IκB kinase complex , IKKα .
50-1	5075-5077	It	substance	giv	coref	51-13
50-2	5078-5081	can	_	_	_	_
50-3	5082-5090	directly	_	_	_	_
50-4	5091-5099	interact	_	_	_	_
50-5	5100-5104	with	_	_	_	_
50-6	5105-5108	the	object[274]	new[274]	_	_
50-7	5109-5116	subunit	object[274]	new[274]	_	_
50-8	5117-5119	of	object[274]	new[274]	_	_
50-9	5120-5123	the	object[274]|abstract[275]|object[276]	new[274]|new[275]|giv[276]	coref|coref	51-3[0_275]|51-3[0_275]
50-10	5124-5127	IκB	object[274]|abstract[275]|object[276]	new[274]|new[275]|giv[276]	_	_
50-11	5128-5134	kinase	object[274]|object[276]	new[274]|giv[276]	_	_
50-12	5135-5142	complex	object[274]	new[274]	_	_
50-13	5143-5144	,	_	_	_	_
50-14	5145-5149	IKKα	abstract	new	_	_
50-15	5150-5151	.	_	_	_	_

#Text=By phosphorylating IκB , this complex is critical for the activation of NF-κB , a major regulator of innate immune response .
51-1	5152-5154	By	_	_	_	_
51-2	5155-5170	phosphorylating	_	_	_	_
51-3	5171-5174	IκB	abstract	giv	coref	52-8
51-4	5175-5176	,	_	_	_	_
51-5	5177-5181	this	_	_	_	_
51-6	5182-5189	complex	_	_	_	_
51-7	5190-5192	is	_	_	_	_
51-8	5193-5201	critical	_	_	_	_
51-9	5202-5205	for	_	_	_	_
51-10	5206-5209	the	abstract[279]	giv[279]	_	_
51-11	5210-5220	activation	abstract[279]	giv[279]	_	_
51-12	5221-5223	of	abstract[279]	giv[279]	_	_
51-13	5224-5229	NF-κB	abstract[279]|substance	giv[279]|giv	_	_
51-14	5230-5231	,	_	_	_	_
51-15	5232-5233	a	substance[281]	new[281]	_	_
51-16	5234-5239	major	substance[281]	new[281]	_	_
51-17	5240-5249	regulator	substance[281]	new[281]	_	_
51-18	5250-5252	of	substance[281]	new[281]	_	_
51-19	5253-5259	innate	substance[281]|abstract[283]	new[281]|new[283]	coref	52-13[288_283]
51-20	5260-5266	immune	substance[281]|abstract|abstract[283]	new[281]|new|new[283]	_	_
51-21	5267-5275	response	substance[281]|abstract[283]	new[281]|new[283]	_	_
51-22	5276-5277	.	_	_	_	_

#Text=InlC was shown to impair phosphorylation of IκB , thereby scaling down the hosts immune response , and is also involved in cell-to-cell spread .
52-1	5278-5282	InlC	abstract	giv	_	_
52-2	5283-5286	was	_	_	_	_
52-3	5287-5292	shown	_	_	_	_
52-4	5293-5295	to	_	_	_	_
52-5	5296-5302	impair	_	_	_	_
52-6	5303-5318	phosphorylation	substance[285]	new[285]	_	_
52-7	5319-5321	of	substance[285]	new[285]	_	_
52-8	5322-5325	IκB	substance[285]|object	new[285]|giv	_	_
52-9	5326-5327	,	_	_	_	_
52-10	5328-5335	thereby	_	_	_	_
52-11	5336-5343	scaling	_	_	_	_
52-12	5344-5348	down	_	_	_	_
52-13	5349-5352	the	abstract[288]	giv[288]	_	_
52-14	5353-5358	hosts	person|abstract[288]	new|giv[288]	_	_
52-15	5359-5365	immune	abstract[288]	giv[288]	_	_
52-16	5366-5374	response	abstract[288]	giv[288]	_	_
52-17	5375-5376	,	_	_	_	_
52-18	5377-5380	and	_	_	_	_
52-19	5381-5383	is	_	_	_	_
52-20	5384-5388	also	_	_	_	_
52-21	5389-5397	involved	_	_	_	_
52-22	5398-5400	in	_	_	_	_
52-23	5401-5413	cell-to-cell	abstract[289]	giv[289]	_	_
52-24	5414-5420	spread	abstract[289]	giv[289]	_	_
52-25	5421-5422	.	_	_	_	_
